EP0433276A1 - Vom wachstumshormon abgeleitete peptide - Google Patents

Vom wachstumshormon abgeleitete peptide

Info

Publication number
EP0433276A1
EP0433276A1 EP88905948A EP88905948A EP0433276A1 EP 0433276 A1 EP0433276 A1 EP 0433276A1 EP 88905948 A EP88905948 A EP 88905948A EP 88905948 A EP88905948 A EP 88905948A EP 0433276 A1 EP0433276 A1 EP 0433276A1
Authority
EP
European Patent Office
Prior art keywords
growth hormone
molecule
activity
peptide
bgh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP88905948A
Other languages
English (en)
French (fr)
Inventor
Roger Aston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Peptide Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27263482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0433276(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878715859A external-priority patent/GB8715859D0/en
Priority claimed from GB878715866A external-priority patent/GB8715866D0/en
Priority claimed from GB878715858A external-priority patent/GB8715858D0/en
Application filed by Peptide Technology Ltd filed Critical Peptide Technology Ltd
Publication of EP0433276A1 publication Critical patent/EP0433276A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Definitions

  • the peptide will generally be antigenic and capable of stimulating the production of antibodies which, when in an appropriate formulation, potentiate the effect of growth hormone.
  • Figure 2 clearly shows enhancement of dwarf mouse growth rate by anti GH antisera, as determined by 35 S 24
  • Sheep Pure Poll Dorset
  • the four groups were subjected to a pre-treatment period of 3 weeks and weighed twice per week.
  • blood was also taken at the times of weighing.
  • blood samples were taken hourly for 18 hours from a catheter.
  • an insulin tolerance test was performed on the animals. All animals were maintained on an ad lib diet of 16% crude protein farm mix (daily refusals were recorded) .

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP88905948A 1987-07-06 1988-07-06 Vom wachstumshormon abgeleitete peptide Withdrawn EP0433276A1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8715858 1987-07-06
GB8715866 1987-07-06
GB878715859A GB8715859D0 (en) 1987-07-06 1987-07-06 Peptides
GB8715859 1987-07-06
GB878715866A GB8715866D0 (en) 1987-07-06 1987-07-06 Peptides
GB878715858A GB8715858D0 (en) 1987-07-06 1987-07-06 Peptides

Publications (1)

Publication Number Publication Date
EP0433276A1 true EP0433276A1 (de) 1991-06-26

Family

ID=27263482

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88905948A Withdrawn EP0433276A1 (de) 1987-07-06 1988-07-06 Vom wachstumshormon abgeleitete peptide

Country Status (6)

Country Link
EP (1) EP0433276A1 (de)
JP (1) JPH03503403A (de)
AU (1) AU630591B2 (de)
DK (1) DK4390A (de)
FI (1) FI900075L (de)
WO (1) WO1989000166A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210180A (en) * 1989-10-27 1993-05-11 American Cyanamid Company Enhancement of porcine somatotropin activity
US6165465A (en) * 1990-05-15 2000-12-26 American Cyanamid Company Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5827819A (en) * 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
US5426096A (en) * 1992-03-18 1995-06-20 Soenksen; Peter Use of human growth hormone
US5338836A (en) * 1992-07-29 1994-08-16 American Cyanamid Company Biologically active porcine somatotropin polypeptides and methods of using the same
AU4986393A (en) * 1992-08-19 1994-03-15 Massey University Methods for effecting a prolonged reduction in measurable fat content and medicaments for use therein
ATE414540T1 (de) * 2002-09-05 2008-12-15 Resistentia Pharmaceuticals Ab Impfstoffe gegen allergien

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8900166A2 *

Also Published As

Publication number Publication date
AU630591B2 (en) 1992-11-05
DK4390D0 (da) 1990-01-08
WO1989000166A3 (en) 1989-01-26
FI900075A7 (fi) 1990-01-05
JPH03503403A (ja) 1991-08-01
WO1989000166A2 (en) 1989-01-12
FI900075A0 (fi) 1990-01-05
DK4390A (da) 1990-03-05
AU1967288A (en) 1989-01-30
FI900075L (fi) 1990-01-05

Similar Documents

Publication Publication Date Title
JPH10512881A (ja) 成長ホルモン放出ホルモンの新規な非常に効力のあるアゴニスト
JP6375089B2 (ja) 強力なアゴニスト作用を有する新規なｇｈ−ｒｈ類似体
AU622858B2 (en) Biologically active molecules
AU630591B2 (en) Growth hormone related peptide
AP71A (en) Peptide structures, immunogens containing them and their uses in the control of fertility.
AU674881B2 (en) Growth hormone potentiating molecules
EP0303488B1 (de) Biologisch aktive Moleküle
JPH06504537A (ja) 魚のｌｈｒｈ類似体
US5401829A (en) Biologically active molecules
JP2000509964A (ja) 成長ホルモン生物活性に対して増強作用を有する生物活性分子、特にペプチド
AU649399B2 (en) GRF peptides
DK173981B1 (da) Farmaceutisk antigenetisk formulering

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19891227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920820

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19931214